LicensingGlobal
Datavault AI to Acquire 19.9% Stake in DataMEDS AI via Expanded Technology Licensing Agreement
Datavault AI has signed a non-binding letter of intent to acquire a 19.9% equity interest in DataMEDS AI in exchange for expanding its existing technology license. The transaction, subject to due diligence and definitive agreements, will enable Datavault AI to retain intellectual property ownership while participating…
Thursday, October 22, 2026